Serum levels of the osteoprotegerin, receptor activator of nuclear factor κ-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction-Reference-Cited by-同舟云学术

Serum levels of the osteoprotegerin, receptor activator of nuclear factor κ-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction

Published:2008-01-01 Issue:4 Volume:46 Page:
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine
language:
Short-container-title:

Author:

Halapas Antonios,Zacharoulis Achilleas,Theocharis Stamatios,Karavidas Apostolos,Korres Dimitrios,Papadopoulos Kostantinos,Katopodis Harris,Stavropoulou Anastasia,Lembessis Peter,Xiromeritis Costas,Zacharoulis Apostolos,Koutsilieris Michael

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2008.091/pdf

Reference39 articles.

1. Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix

2. Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation

3. RANK Ligand and Osteoprotegerin

4. Tissue Distribution of the Death Ligand TRAIL and Its Receptors

5. Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated serum matrix metalloproteinase-2 levels in heart failure patients with reduced ejection fraction and Cheyne-Stokes respiration;Journal of Clinical Sleep Medicine;2022-05

2. Effect of exercise training on left ventricular remodeling in patients with myocardial infarction and possible mechanisms;World Journal of Clinical Cases;2021-08-06

3. Serum Concentrations of Osteogenesis/Osteolysis-Related Factors and Micro-RNA Expression in ST-Elevation Myocardial Infarction;Cardiology Research and Practice;2019-06-02

4. The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease;Angiology;2019-01-29

5. Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk;Heart and Vessels;2017-05-31